Expression of Tenascin-C in intraductal carcinoma of human breast: relationship to invasion

This publication has 26 references indexed in Scilit:

• Co-expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast
  The Journal of Pathology, 1997
• Biologic and oncologic implications of tenascin-C/hexabrachion proteins
  Critical Reviews in Oncology/Hematology, 1997
• Expression of tenascin in invasion border of early breast cancer correlates with higher risk of distant metastasis
  International Journal of Cancer, 1996
• Prognostic classification of breast ductal carcinoma-in-situ
  The Lancet, 1995
• Pathologic findings from the national surgical adjuvant breast project (NSABP) protocol B-17. Intraductal carcinoma (ductal carcinoma in situ)
  Cancer, 1995
• Epithelial Cells Are an Important Source of Tenascin in Normal and Malignant Human Breast Tissue
  Experimental Cell Research, 1994
• Molecular Aspects of Mesenchymal-Epithelial Interactions
  Annual Review of Cell Biology, 1993
• Comparative Analysis of the Expression of Tenascin and Established Prognostic Factors in Human Breast Cancer
  Pathology - Research and Practice, 1993
• Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence
  Cancer, 1989
• Tumors: Wounds That Do Not Heal
  New England Journal of Medicine, 1986